De Novo mutation in Epidermal growth factor receptor (EGFR)-D761Y responding to third generation tyrosine kinase inhibitor Osimertinib: A case report

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epidermal growth factor receptor (EGFR) mutations are the most common accurate gene targets. However, the lack of case reports or cohort studies on the exceptionally rare mutations limit the acquisition of deeper insights. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yingying, Dong, Hongliang, Li, YongCheng, Liu, Lei, Cai, Ying, Wang, Ying, Tian, Shengya, Dai, Chengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302299/
https://www.ncbi.nlm.nih.gov/pubmed/35866776
http://dx.doi.org/10.1097/MD.0000000000029332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302299/
https://www.ncbi.nlm.nih.gov/pubmed/35866776
http://dx.doi.org/10.1097/MD.0000000000029332

Ejemplares similares